References

  1. Blumenthal RS, Morris PB, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of dyslipidemia: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026;87(19):2624-2757. https://doi.org/10.1016/j.jacc.2025.11.016
  2. Kayıkçıoğlu M, Tokgözoğlu L, Kılıçkap M, et al. Data on prevalence of dyslipidemia and lipid values in Turkey: systematic review and meta-analysis of epidemiological studies on cardiovascular risk factors. Turk Kardiyol Dern Ars. 2018;46(7):556-574. https://doi.org/10.5543/tkda.2018.23450
  3. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Hastalık Yönetim Platformu (HYP) tarama ve takip kılavuzu. Ankara: T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü; 2025. Available at: https://hsgm.saglik.gov.tr/depo/HASTALIK_YONETIM_PLATFORMU_HYP_TARAMA_VE_TAKIP_KULAVUZU.pdf (Accessed on July 8, 2026).
  4. Wiggins BS, Barac A, Benziger CP, et al. 2026 dyslipidemia guideline-at-a-glance. J Am Coll Cardiol. 2026;87(19):2617-2623. https://doi.org/10.1016/j.jacc.2026.02.4872
  5. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946. https://doi.org/10.1093/eurheartj/ehac361
  6. Soffer DE, Marston NA, Maki KC, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol. 2024;18(5):e647-e663. https://doi.org/10.1016/j.jacl.2024.08.013
  7. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Birinci Basamağa Yönelik Tanı ve Tedavi Rehberleri 2026. Ankara: T.C. Sağlık Bakanlığı 2026. Available at: https://hsgm.saglik.gov.tr/depo/Yayinlarimiz/Rehberler/Birinci_Basamaga_Yonelik_Tani_ve_Tedavi_Rehberi_2026.pdf (Accessed on July 8, 2026).
  8. T.C. Resmi Gazete. Sosyal Güvenlik Kurumu Sağlık Uygulama Tebliği. Ankara: Başbakanlık Basımevi; 2013. Available at: https://www.resmigazete.gov.tr/eskiler/2013/03/20130324.htm (Accessed on July 8, 2026).

Copyright and license

Copyright © 2026 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Çifçi İ. Potential implications of the 2026 ACC/AHA dyslipidemia guideline for family medicine practice in Türkiye. Turk J Fam Pract. 2026;30(3):300-302. https://doi.org/10.54308/TJFP.2026.1018